middle.news

LTR Pharma Enlists Top Urologist to Accelerate ED Nasal Spray Rollout

8:22am on Wednesday 21st of May, 2025 AEST Healthcare
Read Story

LTR Pharma Enlists Top Urologist to Accelerate ED Nasal Spray Rollout

8:22am on Wednesday 21st of May, 2025 AEST
Key Points
  • Associate Professor Darren Katz joins LTR Pharma's Scientific Advisory Board
  • A/Prof. Katz brings extensive clinical and international expertise in men's health
  • Focus on advancing intranasal ED treatments SPONTAN and ROXUS
  • Appointment strengthens LTR Pharma’s clinical capabilities and prescriber networks
Read Story
middle.

Tap to Read

Tap the card to read the full analysis
about Ltr Pharma (ASX:LTP)
OPEN ARTICLE